Similarities in Coronary Function and Myocardial Deformation Between Psoriasis and Coronary Artery Disease: The Role of Oxidative Stress and Inflammation

Canadian Journal of Cardiology

Volumn 31, Issue 3, 2015, Pages 287-295

  Ikonomidis, Ignatios ^a   Makavos, George ^a   Papadavid, Evangelia ^a   Varoudi, Maria ^a   Andreadou, Ioanna ^b   Gravanis, Kostas ^b   Theodoropoulos, Kostas ^a   Pavlidis, George ^a   Triantafyllidi, Helen ^a   Parissis, John ^a   Paraskevaidis, Ioannis ^a   Rigopoulos, Dimitrios ^a   Lekakis, John ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; MALONALDEHYDE; BIOLOGICAL MARKER;

ADULT; ANGIOCARDIOGRAPHY; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; AUGMENTATION INDEX; BLOOD VESSEL FUNCTION; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY FUNCTION; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; DRUG USE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DEFORMATION; OXIDATIVE STRESS; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS SEVERITY INDEX; PULSE WAVE; SMOKING; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ANGIOGRAPHY; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY BLOOD FLOW; HEART LEFT VENTRICLE FUNCTION; INFLAMMATION; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VASODILATATION;

ADULT; ANGIOGRAPHY; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; PSORIASIS; PULSE WAVE ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VASODILATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84924025813     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.11.002     Document Type: Article

References (43)

1. Gelfand J.M., Weinstein R., Porter S.B., et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005, 141:1537-1541.
2. Kimball A.B., Robinson D., Wu Y., et al. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology 2008, 217:27-37.
3. Vena G.A., Vestita M., Cassano N. Psoriasis and cardiovascular disease. Dermatol Ther 2010, 23:144-151.
4. Laurent S., Cockcroft J., Van Bortel L., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588-2605. European Network for Non-invasive Investigation of Large Arteries.
5. Cruickshank K., Riste L., Anderson S.G., et al. Aortic PWV and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation 2002, 106:2085-2090.
6. Ikonomidis I., Stamatelopoulos K., Lekakis J., Vamvakou G.D., Kremastinos D.T. Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 2008, 199:3-11.
7. Gisondi P., Fantin F., Del Giglio M., et al. Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology 2009, 218:110-113.
8. Ikonomidis I., Tzortzis S., Paraskevaidis I., et al. Association of abnormal coronary microcirculatory function with impaired response of longitudinal left ventricular function during adenosine stress echocardiography in untreated hypertensive patients. Eur Heart J Cardiovasc Imaging 2012, 13:1030-1040.
9. Ikonomidis I., Lekakis J., Papadopoulos C., et al. Incremental value of pulse wave velocity in the determination of coronary microcirculatory dysfunction in never-treated patients with essential hypertension. Am J Hypertens 2008, 21:806-813.
10. Lekakis J., Abraham P., Balbarini A., et al. Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. European J Cardiovasc Prev Rehabil 2011, 18:775-789.
11. El Mongy S., Fathy S., Abdelaziz A., et al. Subclinical atherosclerosis in patients with chronic psoriasis: a potential association. JEur Acad Dermatol Venereol 2010, 24:661-666.
12. Balci D.D., Balci A., Karazincir S., et al. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. JEur Acad Dermatol Venereol 2009, 23:1-6.
13. Osto E., Piaserico S., Maddalozzo A., et al. Impaired coronary flow reserve in young patients affected by severe psoriasis. Atherosclerosis 2012, 221:113-117.
14. Hung C.L., Verma A., Uno H., et al. Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. JAm Coll Cardiol 2010, 56:1812-1822. VALIANT investigators.
15. Ikonomidis I., Lekakis J.P., Nikolaou M., et al. Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation 2008, 117:2662-2669.
16. Ikonomidis I., Lekakis J.P., Nikolaou M., et al. Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis. Heart 2009, 95:1502-1507.
17. Langley R.G., Ellis C.N. Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment. JAm Acad Dermatol 2004, 51:563-569.
18. Ikonomidis I., Ntai K., Kadoglou N.P., et al. The evaluation of pulse wave velocity using Arteriograph and Complior apparatus across multiple cohorts of cardiovascular-related diseases. Int J Cardiol 2013, 168:4890-4892.
19. Sung S.H., Yu W.C., Cheng H.M., et al. Pulsatile hemodynamics and clinical outcomes in acute heart failure. Am J Hypertens 2011, 24:775-782.
20. Lekakis J.P., Ikonomidis I., Protogerou A.D., et al. Arterial wave reflection is associated with severity of extracoronary atherosclerosis in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil 2006, 13:236-242.
21. Hansson G.K., Robertson A.K., Söderberg-Nauclér C. Inflammation and atherosclerosis. Annu Rev Pathol 2006, 1:297-329.
22. Friedewald V.E., Cather J.C., Gelfand J.M., et al. AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol 2008, 102:1631-1643.
23. Prodanovich S., Shelling M.L., Federman D.G., Kirsner R.S. Cytokine milieu in psoriasis and cardiovascular disease may explain the epidemiological findings relating these 2 diseases. Arch Dermatol 2008, 144:1518-1519.
24. Ikonomidis I., Athanassopoulos G., Lekakis J., et al. Myocardial ischemia induces interleukin-6 and tissue factor production in patients with coronary artery disease. Circulation 2005, 112:3272-3279.
25. Wakkee M., Thio H.B., Prens E.P., Sijbrands E.J., Neumann H.A. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007, 190:1-9.
26. Altekin E.R., Koç S., Karakaş M.S., et al. Determination of subclinical atherosclerosis in plaque type psoriasis patients without traditional risk factors for atherosclerosis. Turk Kardiyol Dern Ars 2012, 40:574-580.
27. Yiu K.H., Yeung C.K., Chan H.T., et al. Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation. Br J Dermatol 2011, 164:514-520.
28. Kalam K., Otahal P., Marwick T.H. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart 2014, 100:1673-1680.
29. Ikonomidis I., Tzortzis S., Andreadou I., et al. Increased benefit of interleukin 1 inhibition on vascular function, myocardial deformation, and twisting in patients with coronary artery disease and coexisting rheumatoid arthritis. Circ Cardiovasc Imaging 2014, 7:619-628.
30. Shanq Q., Tam L.S., Sanderson J.E., et al. Impaired left ventricular apical rotation is associated with disease activity of psoriatic arthritis. JRheumatol 2014, 41:706-713.
31. Vinereanu D., Nicolaides E., Boden L., et al. Conduit arterial stiffness is associated with impaired left ventricular subendocardial function. Heart 2003, 89:449-451.
32. Prabhu S.D. Cytokine-induced modulation of cardiac function. Circ Res 2004, 95:1140-1153.
33. Pichler P., Binder T., Höfer P., et al. Two-dimensional speckle tracking echocardiography in heart transplant patients: three-year follow-up of deformation parameters and ejection fraction derived from transthoracic echocardiography. Eur Heart J Cardiovasc Imaging 2012, 13:181-186.
34. Paterson I., Mielnicz L.M., O'Meara E., So A., White J.A. Imaging heart failure: current and future applications. Can J Cardiol 2013, 29:317-328.
35. Piot C., Croisille P., Staat P., et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. NEngl J Med 2008, 359:473-481.
36. Mewton N., Croisille P., Gahide G., et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. JAm Coll Cardiol 2010, 55:1200-1205.
37. Silverborn M., Ambring A., Nilsson F., Friberg P., Jeppsson A. Vascular resistance and endothelial function in cyclosporine-treated lung transplant recipients. Transpl Int 2006, 19:974-981.
38. Seibert F.S., Steltzer J., Melilli E., et al. Differential impact of belatacept and cyclosporine A on central aortic blood pressure and arterial stiffness after renal transplantation. Clin Transplant 2014, 28:1004-1009.
39. Gelfand J.M., Neimann A.L., Shin D.B., et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006, 296:1735-1741.
40. Armstrong A.W., Harskamp C.T., Ledo L., Rogers J.H., Armstrong E.J. Coronary artery disease in patients with psoriasis referred for coronary angiography. Am J Cardiol 2012, 109:976-980.
41. Mallbris L., Akre O., Granath F., et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004, 19:225-230.
42. Wong B.W., Meredith A., Lin D., McManus B.M. The biological role of inflammation in atherosclerosis. Can J Cardiol 2012, 28:631-641.
43. Verma S., Gupta M., Ridker P.M. Therapeutic targeting of inflammation in atherosclerosis: we are getting closer?. Can J Cardiol 2012, 28:619-622.